Warning! GuruFocus detected
7 Severe warning signs
with P09.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Pacific Biosciences of California Inc
NAICS : 325413
SIC : 3845
ISIN : US69404D1081
Description
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.58 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 1.33 | |||||
| Debt-to-EBITDA | -2.77 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -2.36 | |||||
| Beneish M-Score | -3.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.8 | |||||
| 3-Year EBITDA Growth Rate | 11.8 | |||||
| 3-Year EPS without NRI Growth Rate | -34.7 | |||||
| 3-Year FCF Growth Rate | -8.6 | |||||
| 3-Year Book Growth Rate | -21.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 30.97 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 18.16 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.21 | |||||
| 9-Day RSI | 41.44 | |||||
| 14-Day RSI | 41.64 | |||||
| 3-1 Month Momentum % | -24.66 | |||||
| 6-1 Month Momentum % | -11.08 | |||||
| 12-1 Month Momentum % | -58.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.48 | |||||
| Quick Ratio | 6.59 | |||||
| Cash Ratio | 5.88 | |||||
| Days Inventory | 198.31 | |||||
| Days Sales Outstanding | 74.07 | |||||
| Days Payable | 51.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10 | |||||
| Shareholder Yield % | 22.27 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 24.21 | |||||
| Operating Margin % | -188.73 | |||||
| Net Margin % | -201.18 | |||||
| FCF Margin % | -137.45 | |||||
| ROE % | -55.28 | |||||
| ROA % | -20.29 | |||||
| ROIC % | -29.95 | |||||
| 3-Year ROIIC % | 175.33 | |||||
| ROC (Joel Greenblatt) % | -277.54 | |||||
| ROCE % | -20.39 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.12 | |||||
| PB Ratio | 0.66 | |||||
| EV-to-EBIT | -2.1 | |||||
| EV-to-Forward-EBIT | -2.66 | |||||
| EV-to-EBITDA | -2.56 | |||||
| EV-to-Forward-EBITDA | -3.02 | |||||
| EV-to-Revenue | 4.04 | |||||
| EV-to-Forward-Revenue | 3.87 | |||||
| EV-to-FCF | -2.93 | |||||
| Price-to-GF-Value | 0.22 | |||||
| Price-to-Median-PS-Value | 0.26 | |||||
| Earnings Yield (Greenblatt) % | -47.62 | |||||
| FCF Yield % | -62.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pacific Biosciences of California Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 142.63 | ||
| EPS (TTM) (€) | -1.528 | ||
| Beta | 1.45 | ||
| 3-Year Sharpe Ratio | -0.32 | ||
| 3-Year Sortino Ratio | -0.44 | ||
| Volatility % | 108.24 | ||
| 14-Day RSI | 41.64 | ||
| 14-Day ATR (€) | 0.076494 | ||
| 20-Day SMA (€) | 1.20303 | ||
| 12-1 Month Momentum % | -58.65 | ||
| 52-Week Range (€) | 1.0702 - 3.48 | ||
| Shares Outstanding (Mil) | 297.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pacific Biosciences of California Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pacific Biosciences of California Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pacific Biosciences of California Inc Frequently Asked Questions
What is Pacific Biosciences of California Inc(STU:P09)'s stock price today?
The current price of STU:P09 is €1.14. The 52 week high of STU:P09 is €3.48 and 52 week low is €1.07.
When is next earnings date of Pacific Biosciences of California Inc(STU:P09)?
The next earnings date of Pacific Biosciences of California Inc(STU:P09) is 2025-05-09 Est..
Does Pacific Biosciences of California Inc(STU:P09) pay dividends? If so, how much?
Pacific Biosciences of California Inc(STU:P09) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers